Nicola P. Klein - Concepedia

Author

Nicola P. Klein

Also Known As

Klein, Nicola P, N KLEIN, N Klein, N P Klein, N. Klein, N. P. Klein, N.P. Klein, Nick Klein, Nicola P. Klein, Nicola Klein

437

Publications

19.4K

Citations

H-Index

182

Concepts

All Affiliations

Kaiser Permanente Centers for Disease Control and Prevention Kaiser Permanente Center for Health Research HealthPartners National Center for Immunization and Respiratory Diseases

About

Nicola P. Klein is an author at Kaiser Permanente specializing in medicine, vaccination, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Education	3	3	178
2	Health Sciences	2	2	106
3	Arts	1	1	20
4	Language Studies	1	1	20
5	Law	1	1	27

Nicola P. Klein

241

Publications

17.6K

Citations

H-Index

Page 1

	Year	Citations
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents Robert W. Frenck, Nicola P. Klein, Nicholas Kitchin, New England Journal of Medicine	2021	913
Surveillance for Adverse Events After COVID-19 mRNA Vaccination Nicola P. Klein, Ned Lewis, Kristin Goddard, JAMA	2021	627
Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children Nicola P. Klein, Joan Bartlett, Ali Rowhani‐Rahbar, New England Journal of Medicine	2012	570
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis, New England Journal of Medicine	2021	490
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, MMWR Morbidity and Mortality Weekly Report	2022	466
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, MMWR Morbidity and Mortality Weekly Report	2022	427
Risk of anaphylaxis after vaccination in children and adults Michael M. McNeil, Eric Weintraub, Jonathan Duffy, Journal of Allergy and Clinical Immunology VaccinationVaccine SafetyAllergyAllergy MedicineVaccine Efficacy	2015	377
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. Margherita Doria, Nicola P. Klein, Robert Lucito, The EMBO Journal Viral ReplicationMolecular VirologyViral HepatitisNatural SciencesImmunology	1995	310
Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures Nicola P. Klein, Bruce Fireman, W. Katherine Yih, PEDIATRICS	2010	310
Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis Roger Baxter, Joan Bartlett, Bruce Fireman, PEDIATRICS	2017	252

Page 1